Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas

JAMA

Volumn 308, Issue 18, 2012, Pages 1881-1888

  Jakola, Asgeir S ^a,b,d   Myrmel, Kristin S ^c   Kloster, Roar ^c   Torp, Sverre H ^b   Lindal, Sigurd ^c   Unsgård, Geirmund ^a,b,d   Solheim, Ole ^a,b,d  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d National Advisory Unit in Ultrasound and Image Guided Surgery   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN BIOPSY; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; EARLY INTERVENTION; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; SURVIVAL TIME; UNIVERSITY HOSPITAL; WATCHFUL WAITING;

EID: 84868667212     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.12807     Document Type: Article

References (45)

1. van den Bent MJ, Wefel JS, Schiff D, et al. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol. 2011;12 (6):583-593.
2. Cavaliere R, Lopes MBS, Schiff D. Low-grade gliomas: an update on pathology and therapy. Lancet Neurol. 2005;4(11):760-770.
3. Pouratian N, Asthagiri A, Jagannathan J, Shaffrey ME, Schiff D. Surgery insight: the role of surgery in the management of low-grade gliomas. Nat Clin Pract Neurol. 2007;3(11):628-639.
4. Veeravagu A, Jiang B, Chang SD, Black KL, Patil CG. Biopsy versus resection for the management of low-grade gliomas. Cochrane Database Syst Rev. 2011;(9):CD009319.
5. Wessels PH, Weber WEJ, Raven G, Ramaekers FCS, Hopman AHN, Twijnstra A. Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol. 2003;2(7):395-403.
6. Tinetti ME, Studenski SA. Comparative effectiveness research and patients with multiple chronic conditions. N Engl J Med. 2011;364(26):2478-2481.
7. Recht LD, Lew R, Smith TW. Suspected low-grade glioma: is deferring treatment safe? Ann Neurol. 1992;31(4):431-436.
8. Reijneveld JC, Sitskoorn MM, Klein M, Nuyen J, Taphoorn MJ. Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas. Neurology. 2001;56(5):618-623.
9. Shaw EG, Berkey B, Coons SW, et al. Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial. J Neurosurg. 2008;109(5):835-841.
10. McGirt MJ, Chaichana KL, Attenello FJ, et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery. 2008;63(4):700-707.
11. Chaichana KL, McGirt MJ, Laterra J, Olivi A, Quiñones-Hinojosa A. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. J Neurosurg. 2009;112(1):10-17.
12. Ahmadi R, Dictus C, Hartmann C, et al. Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients. Acta Neurochir (Wien). 2009;151(11):1359-1365.
13. Smith JS, Chang EF, Lamborn KR, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol. 2008;26(8):1338-1345.
14. Keles GE, Lamborn KR, Berger MS. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg. 2001;95(5):735-745.
15. Lang FF, Gilbert MR. Diffusely infiltrative low-grade gliomas in adults. J Clin Oncol. 2006;24(8):1236-1245.
16. Seiz M, Freyschlag CF, Schenkel S, et al. management of patients with low-grade gliomas - a survey among German neurosurgical departments. Cen Eur Neurosurg. 2011;72(4):186-191.
17. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457.
18. Solheim O, Jakola AS, Gulati S, Johannesen TB. Incidence and causes of perioperative mortality after primary surgery for intracranial tumors: a national, population-based study. J Neurosurg. 2012;116(4):825-834.
19. Brommeland T, Hennig R. A new procedure for frameless computer navigated stereotaxy. Acta Neurochir (Wien). 2000;142(4):443-447.
20. Brommeland T, Hennig R. Mechanical accuracy of a new stereotactic guide. Acta Neurochir (Wien). 2000;142(4):449-454.
21. Brommeland T, Kloster R, Ingebrigtsen T. A fouryear experience with a stereotactic computer in a small neurosurgical department. Surg Neurol. 2002;57(3):190-194.
22. Unsgaard G, Rygh OM, Selbekk T, et al. Intraoperative 3D ultrasound in neurosurgery. Acta Neurochir (Wien). 2006;148(3):235-253.
23. Berntsen EM, Gulati S, Solheim O, et al. Functional magnetic resonance imaging and diffusion tensor tractography incorporated into an intraoperative 3-dimensional ultrasound-based neuronavigation system: impact on therapeutic strategies, extent of resection, and clinical outcome. Neurosurgery. 2010;67(2):251-264.
24. Gronningsaeter A, Kleven A, Ommedal S, et al. Sono W and, an ultrasound-based neuronavigation system. Neurosurgery. 2000;47(6):1373-1379.
25. Unsgaard G, Ommedal S, Muller T, Gronningsaeter A, Nagelhus Hernes TA. Neuronavigation by intraoperative three-dimensional ultrasound: initial experience during brain tumor resection. Neurosurgery. 2002;50(4):804-812.
26. Radner H, Blümcke I, Reifenberger G, Wiestler OD. The new WHO classification of tumors of the nervous system 2000: pathology and genetics [in German]. Pathologe. 2002;23(4):260-283.
27. Aldape K, Simmons ML, Davis RL, et al. Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study. Cancer. 2000;88(10):2342-2349.
28. Sawaya R, Hammoud M, Schoppa D, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery. 1998;42(5):1044-1055.
29. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol. 2002;20(8):2076-2084.
30. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
31. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM. Evaluation of Chemotherapeutic Agents: Symposium, New York Academy of Medicine. New York, NY: Columbia University Press; 1949:191-205.
32. van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. JNeurol Neurosurg Psychiatry. 1998;64(5):581-587.
33. Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer. 2006;106(6):1358-1363.
34. Johannesen TB, Langmark F, Lote K. Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. J Neurosurg. 2003;99(5):854-862.
35. Claus EB, Horlacher A, Hsu L, et al. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer. 2005;103(6):1227-1233.
36. Duffau H, Peggy Gatignol ST, Mandonnet E, Capelle L, Taillandier L. Intraoperative subcortical stimulation mapping of language pathways in a consecutive series of 115 patients with grade II glioma in the left dominant hemisphere. J Neurosurg. 2008;109(3):461-471.
37. Mandonnet E, Delattre J-Y, Tanguy M-L, et al. Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol. 2003;53(4):524-528.
38. van den Bent MJ, Vogelbaum MA, Wen PY, Macdonald DR, Chang SM. End point assessment in gliomas: novel treatments limit usefulness of classical macdonald's criteria. J Clin Oncol. 2009;27(18):2905-2908.
39. Sanai N, Chang S, Berger MS. Low-grade gliomas in adults. J Neurosurg. 2011;115(5):948-965.
40. Shaw EG, Wisoff JH. Prospective clinical trials of intracranial low-grade glioma in adults and children. Neuro Oncol. 2003;5(3):153-160.
41. van den Bent MJ, Afra D, de Witte O, et al; EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet. 2005;366(9490):985-990.
42. Karim AB, Maat B, Hatlevoll R, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys. 1996;36(3):549-556.
43. Johannesen TB, Langmark F, Lote K. Cause of death and long-term survival in patients with neuro-epithelial brain tumours: a population-based study. Eur J Cancer. 2003;39(16):2355-2363.
44. McGirt MJ, Villavicencio AT, Bulsara KR, Friedman AH. MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen. Surg Neurol. 2003;59(4):277-281.
45. Jackson RJ, Fuller GN, Abi-Said D, et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol. 2001;3(3):193-200.